We investigated antibody titers and avidity after heterologous versus homologous coronavirus disease 2019 vaccination over 6 months after the second dose. We found a significantly higher avidity in regimens including at least 1 dose of the adenoviral vector vaccine ChAdOx1-S compared with 2 doses of the mRNA vaccine BNT162b2.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494481 | PMC |
| http://dx.doi.org/10.1093/infdis/jiac379 | DOI Listing |
Publication Analysis
Top Keywords
coronavirus disease
8
disease 2019
8
2019 vaccination
8
regimen coronavirus
4
vaccination influences
4
influences extent
4
extent kinetics
4
kinetics antibody
4
antibody avidity
4
avidity investigated
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!